ViralVacDB | Details of Viral Vaccine

Middle East respiratory syndrome (MERS)

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a novel coronavirus (Middle East respiratory syndrome coronavirus, or MERS‐CoV) that was first identified in Saudi Arabia in 2012.Typical MERS symptoms include fever, cough and shortness of breath. Pneumonia is common, but not always present.Approximately 35% of reported patients with MERS-CoV infection have died.
Detailed Information
Disease Name MERS
Virus Name MERS-CoV virus
Capsid Symmetry Helical
Capsid Naked/Enveloped Enveloped
Family Coronaviridae
Genus Betacoronavirus
Genome Single-strand RNA
Proteome 10 predicted open reading frames (ORFs). The ORFs for the structural proteins are arranged as 5′-ORF1a/b-S-E-M-N-poly(A)-3′ and carries genes encoding accessory proteins (APs; 3, 4a, 4b, and 5)
Antigenic Target Spike glycoprotein (S)
Incubation Period Approximately 5 days (range 2-14 days)
Zoonotic Evidence Zoonosis
Host Human, Tomb bat
Chronology_Time 2012
Regions Affected Saudi Arabia, United Arab Emirates, The Republic of Korea, Middle East and Africa
Susceptible Age Group People belonging 41–60 age group
Transmission Route Respiratory infection, close contact
Symptoms Fever, cough and shortness of breath
Co-infection NA
Genome Reference Genome Link
Proteome Reference Proteome Link
Reference Reference